(3S,4S)-Tofacitinib Catalog No.:M9956-2 [2H]C([2H])([2H])N1CCC(CC1)C1=CNC2=CC=C(CCS(=O)(=O)NC)C=C12

[2H]C([2H])([2H])N1CCC(CC1)C1=CNC2=CC=C(CCS(=O)(=O)NC)C=C12

3ClH/c1-33-15-17-34(18-16-33)22-9-11-23(12-10-22)35-19-26(27-28(30)31-20-32-29(27)35)21-7-13-25(14-8-21)36-24-5-3-2-4-6-24

Chresta CM

33)34)20-14(39-23)6-7-17(28-20)27-19-13(24)10-25-22(29-19)26-12-8-15(35-3)18(37-5)16(9-12)36-4/h6-10H

(2014) Oncogene

(3S,4S)-Tofacitinib Catalog No.:M9956-2 [2H]C([2H])([2H])N1CCC(CC1)C1=CNC2=CC=C(CCS(=O)(=O)NC)C=C12Tofacitinib, also known as tasocitinib, CP 690550, is a Janus kinase (JAK) inhibitor. Product information CAS Number: 1092578 47 6 Molecular Weight: 312. 37 Formula: C16H20N6O Chemical Name: 3 [(3S,4S) 4 methyl 3 [methyl({7H pyrrolo[2,3 d]pyrimidin 4 yl})amino]piperidin 1 yl] 3 oxopropanenitrile Smiles: CN([C@@H]1CN(CC[C@@H]1C)C(=O)CC#N)C1N=CN=C2NC=CC2=1 InChiKey: UJLAWZDWDVHWOW WCQYABFASA N InChi: InChI=1S C16H20N6O c1 11 5 8 22(14(23)3 6 17)9